Are protections in place to prevent bribing of FDA officials? With drugs such as Lipitor achieving lifetime sales well over $100 billion, the motivation to use any means available to…
Posts published in October 2017
IT and software technologies attract the most patent lawsuits, but pharmaceuticals are targeted too In the US, patent infringement cases nearly doubled from the year 2010 to 2014. Sixty-one percent…
This is part six of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
This is part five of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
This is part four of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
This is part three of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
This is part two of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
This is part one of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
Drug patent portfolios often include patents specifically designed to keep rivals from introducing innovative improvements for a period of time The so-called fencing patent, or dominating patent, is a patent…
Clinical researchers are beginning to ask why pharmacists are not well-represented on clinical drug trial teams. When most people think of clinical drug trials, they consider patients, doctors, and the…